Biosensors: Reports Financial Results For Fiscal Year 2013
For Q4 FY13, Biosensors reported total revenue of US$88.8 million, comparable to a year ago of US$88.2 million.
Product revenue of US$76.4 million, a 17% increase over US$65.3 million in Q4 FY12. Correspondingly, IVP sales rose to US$73.3 million, up 18% from US$61.9 million in Q4 FY12, driven by increased DES sales. CCP sales revenue was US$3.1 million, compared to US$3.5 million in Q4 FY12.
Licensing and royalties revenue was US$12.4 million, down US$10.4 million or 46% from US$22.8 million in Q4 FY12.
The Company has recommended a final dividend of US$0.02 per share for the financial year ended 31 March 2013 amounting to US$34.5 million, subject to shareholders' approval...